<DOC>
	<DOCNO>NCT00209417</DOCNO>
	<brief_summary>It well know X-ray contrast medium affect kidney function patient , especially administer intra-arterially , patient already suffer reduced kidney function diabetes mellitus may increase risk . It widely accept use low-osmolar iso-osmolar contrast medium , especially patient risk contrast media-induced nephropathy . However , little know intravenous use X-ray contrast medium risk patient , contrast-enhanced CT examination . The main purpose study evaluate compare effect kidney function two contrast medium , iso-osmolar iodixanol low-osmolar iopamidol patient risk kidney damage associate injection contrast medium . Due iso-osmolar feature , expect less influence renal function follow administration iodixanol . A standard hydration procedure , base available guideline give patient prevent negative effect kidney . Serum creatinine ( SCr ) concentration measure 7 day contrast medium administration evaluate effect renal function .</brief_summary>
	<brief_title>Renal Effects Two Iodinated Contrast Media Patients Risk Undergoing Computed Tomography</brief_title>
	<detailed_description>GEHC decide provide detail</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Patients combination diabetes mellitus ( type I II ) renal impairment refer contrastenhanced CT examination . Concurrent administration potentially nephroprotective nephrotoxic drug permit . Patients undergoing dialysis kidney transplantation include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Iodixanol</keyword>
	<keyword>Iopamidol</keyword>
	<keyword>compute tomography</keyword>
	<keyword>Patients pre-existing renal impairment diabetes</keyword>
</DOC>